T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.42B |
| 2 |
Wynn Resorts
WYNN
|
+$992M |
| 3 |
Eli Lilly
LLY
|
+$964M |
| 4 |
Visa
V
|
+$700M |
| 5 |
American Airlines Group
AAL
|
+$626M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.24B |
| 2 |
Dollar Tree
DLTR
|
+$1.13B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.03B |
| 4 |
Gilead Sciences
GILD
|
+$792M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$788M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.72% |
| 2 | Consumer Discretionary | 13.88% |
| 3 | Financials | 12.99% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOAH
1226
Noah Holdings
NOAH
$590M
| $13.1M | ﹤0.01% |
975,754
-30,053
| -3% | -$455K |
|
|
PTLA
1227
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $13.1M | ﹤0.01% |
517,653
-49,926
| -9% | -$1.31M |
|
1228
FIVE9
FIVN
$2.41B
| $13.1M | ﹤0.01% |
2,000,540
+166,880
| +9% | +$1.08M |
|
|
IMDZ
1229
DELISTED
Immune Design Corp.
IMDZ
| $13.1M | ﹤0.01% |
+740,241
| New | +$9.37M |
|
1230
Prestige Consumer Healthcare
PBH
$2.41B
| $13.1M | ﹤0.01% |
403,600
+7,900
| +2% | +$264K |
|
|
VAR
1231
DELISTED
Varian Medical Systems, Inc.
VAR
| $13M | ﹤0.01% |
185,631
+3,649
| +2% | +$269K |
|
1232
Huntington Bancshares
HBAN
$36.1B
| $13M | ﹤0.01% |
1,338,015
+25,300
| +2% | +$248K |
|
1233
Helen of Troy
HELE
$699M
| $13M | ﹤0.01% |
247,400
+4,500
| +2% | +$252K |
|
|
SIX
1234
DELISTED
Six Flags Entertainment Corp.
SIX
| $13M | ﹤0.01% |
377,800
-4,400
| -1% | -$165K |
|
|
OXFD
1235
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $13M | ﹤0.01% |
849,900
-900
| -0.1% | -$13.8K |
|
|
NWHM
1236
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $13M | ﹤0.01% |
960,700
+188,454
| +24% | +$2.57M |
|
|
BID
1237
DELISTED
Sotheby's
BID
| $12.9M | ﹤0.01% |
362,336
-9,100
| -2% | -$358K |
|
1238
NETSCOUT
NTCT
$2.88B
| $12.9M | ﹤0.01% |
282,400
+4,300
| +2% | +$193K |
|
|
NPSP
1239
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $12.9M | ﹤0.01% |
497,200
+5,900
| +1% | +$169K |
|
1240
Deckers Outdoor
DECK
$12.7B
| $12.9M | ﹤0.01% |
795,360
+10,800
| +1% | +$165K |
|
1241
Sixth Street Specialty
TSLX
$1.79B
| $12.8M | ﹤0.01% |
801,340
+6,100
| +0.8% | +$114K |
|
|
FDO
1242
DELISTED
FAMILY DOLLAR STORES
FDO
| $12.8M | ﹤0.01% |
166,073
-158,231
| -49% | -$11.7M |
|
1243
Avient
AVNT
$4.23B
| $12.8M | ﹤0.01% |
359,030
+327,500
| +1,039% | +$12.9M |
|
|
NMBL
1244
DELISTED
Nimble Storage, Inc.
NMBL
| $12.7M | ﹤0.01% |
490,715
+166,917
| +52% | +$4.54M |
|
|
DXYN
1245
DELISTED
Dixie Group Inc
DXYN
| $12.6M | ﹤0.01% |
1,458,720
+12,500
| +0.9% | +$112K |
|
|
SWY
1246
DELISTED
SAFEWAY INC
SWY
| $12.6M | ﹤0.01% |
367,633
+6,800
| +2% | +$235K |
|
|
CETV
1247
DELISTED
Central European Media Enterprises Ltd
CETV
| $12.6M | ﹤0.01% |
5,588,772
+9,000
| +0.2% | +$22.3K |
|
|
OTIC
1248
DELISTED
Otonomy, Inc.
OTIC
| $12.5M | ﹤0.01% |
+521,100
| New | +$10.3M |
|
1249
Corpay
CPAY
$27.4B
| $12.5M | ﹤0.01% |
87,773
-194,662
| -69% | -$26.8M |
|
|
CATM
1250
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $12.4M | ﹤0.01% |
352,794
-2,200
| -0.6% | -$78.4K |
|
Similar funds
T. Rowe Price Associates's Q3 2014 Portfolio in Review
As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
- T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
- T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
- T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.
Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.